BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19637952)

  • 1. Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature.
    Raisch DW; Straight TM; Holodniy M
    Pharmacotherapy; 2009 Aug; 29(8):988-92. PubMed ID: 19637952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of oseltamivir when coadministered with probenecid.
    Rayner CR; Chanu P; Gieschke R; Boak LM; Jonsson EN
    J Clin Pharmacol; 2008 Aug; 48(8):935-47. PubMed ID: 18524996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tolerability of oseltamivir combined with probenecid.
    Holodniy M; Penzak SR; Straight TM; Davey RT; Lee KK; Goetz MB; Raisch DW; Cunningham F; Lin ET; Olivo N; Deyton LR
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3013-21. PubMed ID: 18559644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe-associated immune thrombocytopenia.
    Pattis P; Wiedermann CJ
    Ann Pharmacother; 2008 Mar; 42(3):430-3. PubMed ID: 18252832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged thrombocytopenia associated with isotretinoin.
    Moeller KE; Touma SC
    Ann Pharmacother; 2003 Nov; 37(11):1622-4. PubMed ID: 14565796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide-associated thrombocytopenia.
    Duyvendak M; Naunton M; Kingma BJ; Brouwers JR
    Ann Pharmacother; 2005 Nov; 39(11):1936-9. PubMed ID: 16219892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of probenecid and cephalexin into breast milk.
    Ilett KF; Hackett LP; Ingle B; Bretz PJ
    Ann Pharmacother; 2006 May; 40(5):986-9. PubMed ID: 16551765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspected beta-antagonist-induced thrombocytopenia.
    Stamm PL; Jenkins JK; Vigrass HG
    Ann Pharmacother; 2005 Mar; 39(3):555-8. PubMed ID: 15701771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory action.
    Brinker AD; Beitz J
    Am J Hematol; 2002 Aug; 70(4):313-7. PubMed ID: 12210813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
    Wattanagoon Y; Stepniewska K; LindegÄrdh N; Pukrittayakamee S; Silachamroon U; Piyaphanee W; Singtoroj T; Hanpithakpong W; Davies G; Tarning J; Pongtavornpinyo W; Fukuda C; Singhasivanon P; Day NP; White NJ
    Antimicrob Agents Chemother; 2009 Mar; 53(3):945-52. PubMed ID: 19104028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.
    Hoffman KB; Demakas A; Erdman CB; Dimbil M; Doraiswamy PM
    BMJ; 2013 Jul; 347():f4656. PubMed ID: 23881998
    [No Abstract]   [Full Text] [Related]  

  • 17. Memantine-induced myoclonus and delirium exacerbated by trimethoprim.
    Moellentin D; Picone C; Leadbetter E
    Ann Pharmacother; 2008 Mar; 42(3):443-7. PubMed ID: 18303133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic epidermal necrolysis after treatment with oseltamivir: case report].
    Luna P; Zuazaga M; Chede C; Entin E; Larralde M
    Arch Argent Pediatr; 2010 Jun; 108(3):e76-8. PubMed ID: 20544126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe allergic reaction to hydrochlorothiazide mimicking septic shock.
    Mineo MC; Cheng EY
    Pharmacotherapy; 2009 Mar; 29(3):357-61. PubMed ID: 19249954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.